CITALOPRAM

CITALOPRAM was reported 137339 times

These side effects are most commonly reported by patients taking CITALOPRAM:

# Side effect Count
0 FATIGUE 9214
1 NAUSEA 8411
2 DRUG INEFFECTIVE 7542
3 HEADACHE 6885
4 DIARRHOEA 6391
5 PAIN 6081
6 DIZZINESS 5869
7 FALL 5754
8 ANXIETY 5581
9 DYSPNOEA 5466
10 OFF LABEL USE 5407
11 DEPRESSION 5303
12 TOXICITY TO VARIOUS AGENTS 5282
13 VOMITING 5113
14 DRUG INTERACTION 4529
15 COMPLETED SUICIDE 4419
16 MALAISE 4347
17 ASTHENIA 4225
18 ARTHRALGIA 4002
19 DEATH 3820
20 INSOMNIA 3679
21 RASH 3313
22 CONFUSIONAL STATE 3299
23 SOMNOLENCE 3272
24 PYREXIA 3270
25 WEIGHT DECREASED 3239
26 PNEUMONIA 3210
27 CONDITION AGGRAVATED 3073
28 PAIN IN EXTREMITY 3068
29 TREMOR 3062
30 OVERDOSE 3059
31 WEIGHT INCREASED 3038
32 BACK PAIN 3017
33 CONSTIPATION 2927
34 PRURITUS 2893
35 DRUG ABUSE 2808
36 COUGH 2803
37 FEELING ABNORMAL 2740
38 HYPERTENSION 2731
39 ABDOMINAL PAIN 2723
40 SUICIDAL IDEATION 2718
41 HYPERHIDROSIS 2705
42 DECREASED APPETITE 2460
43 HYPOTENSION 2434
44 GAIT DISTURBANCE 2301
45 URINARY TRACT INFECTION 2212
46 CHEST PAIN 2210
47 ANAEMIA 2006
48 ABDOMINAL PAIN UPPER 2005
49 ACUTE KIDNEY INJURY 2005
50 LOSS OF CONSCIOUSNESS 1981
51 SUICIDE ATTEMPT 1960
52 MEMORY IMPAIRMENT 1909
53 AGITATION 1888
54 HYPERSENSITIVITY 1868
55 PARAESTHESIA 1830
56 HYPOAESTHESIA 1796
57 DRUG HYPERSENSITIVITY 1793
58 HYPONATRAEMIA 1780
59 RENAL FAILURE 1768
60 MUSCLE SPASMS 1760
61 INTENTIONAL OVERDOSE 1758
62 ELECTROCARDIOGRAM QT PROLONGED 1730
63 NASOPHARYNGITIS 1727
64 DEHYDRATION 1678
65 ERYTHEMA 1668
66 ABDOMINAL DISCOMFORT 1664
67 ASTHMA 1647
68 CHRONIC KIDNEY DISEASE 1618
69 BLOOD PRESSURE INCREASED 1612
70 SYNCOPE 1608
71 MYALGIA 1593
72 SEROTONIN SYNDROME 1527
73 CARDIAC ARREST 1507
74 ALOPECIA 1493
75 RHEUMATOID ARTHRITIS 1492
76 JOINT SWELLING 1485
77 FOETAL EXPOSURE DURING PREGNANCY 1482
78 PALPITATIONS 1468
79 HALLUCINATION 1410
80 OEDEMA PERIPHERAL 1406
81 BALANCE DISORDER 1405
82 PERIPHERAL SWELLING 1405
83 GENERAL PHYSICAL HEALTH DETERIORATION 1392
84 MUSCULAR WEAKNESS 1388
85 TACHYCARDIA 1367
86 CEREBROVASCULAR ACCIDENT 1363
87 PRODUCT USE IN UNAPPROVED INDICATION 1357
88 INJECTION SITE PAIN 1336
89 PRODUCT USE ISSUE 1300
90 CONTUSION 1295
91 DRUG DOSE OMISSION 1285
92 VISION BLURRED 1275
93 SEIZURE 1271
94 MIGRAINE 1258
95 PSORIASIS 1234
96 COVID-19 1231
97 DISTURBANCE IN ATTENTION 1218
98 URTICARIA 1204
99 INFECTION 1202
100 PRODUCT DOSE OMISSION ISSUE 1199
101 AMNESIA 1191
102 DIABETES MELLITUS 1184
103 THROMBOCYTOPENIA 1177
104 CHILLS 1162
105 GASTROOESOPHAGEAL REFLUX DISEASE 1162
106 INTENTIONAL PRODUCT MISUSE 1155
107 SINUSITIS 1153
108 HEART RATE INCREASED 1151
109 MYOCARDIAL INFARCTION 1149
110 PULMONARY EMBOLISM 1145
111 ACCIDENTAL OVERDOSE 1127
112 CHEST DISCOMFORT 1119
113 STRESS 1103
114 CARDIO-RESPIRATORY ARREST 1093
115 DRY MOUTH 1091
116 BLOOD GLUCOSE INCREASED 1088
117 SEPSIS 1086
118 SLEEP DISORDER 1086
119 HAEMOGLOBIN DECREASED 1085
120 DEPRESSED MOOD 1082
121 UPPER RESPIRATORY TRACT INFECTION 1081
122 ABDOMINAL DISTENSION 1077
123 AGGRESSION 1075
124 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1073
125 VISUAL IMPAIRMENT 1070
126 IRRITABILITY 1063
127 DYSPHAGIA 1062
128 HEPATIC ENZYME INCREASED 1042
129 DYSPEPSIA 1025
130 FLUSHING 1021
131 DRUG INTOLERANCE 1016
132 MUSCULOSKELETAL STIFFNESS 1012
133 INCORRECT DOSE ADMINISTERED 1000
134 GASTROINTESTINAL HAEMORRHAGE 995
135 CONVULSION 986
136 INFLUENZA 954
137 BRONCHITIS 953
138 MEDICATION ERROR 952
139 EXPOSURE DURING PREGNANCY 946
140 RESTLESSNESS 946
141 EMOTIONAL DISTRESS 943
142 ARTHRITIS 939
143 PANIC ATTACK 936
144 COGNITIVE DISORDER 932
145 ATRIAL FIBRILLATION 923
146 OROPHARYNGEAL PAIN 920
147 LETHARGY 917
148 DEEP VEIN THROMBOSIS 915
149 BRADYCARDIA 891
150 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 884
151 HYPOKALAEMIA 882
152 INTENTIONAL PRODUCT USE ISSUE 871
153 RASH ERYTHEMATOUS 871
154 VERTIGO 865
155 RESPIRATORY FAILURE 863
156 WHITE BLOOD CELL COUNT DECREASED 854
157 DYSKINESIA 853
158 DISORIENTATION 847
159 FLUID RETENTION 847
160 INFUSION RELATED REACTION 842
161 MOBILITY DECREASED 838
162 DRUG WITHDRAWAL SYNDROME 831
163 NEUTROPENIA 824
164 WITHDRAWAL SYNDROME 824
165 RESPIRATORY ARREST 815
166 WHEEZING 808
167 INJURY 800
168 OXYGEN SATURATION DECREASED 798
169 DEPRESSED LEVEL OF CONSCIOUSNESS 794
170 NEUROPATHY PERIPHERAL 791
171 SWELLING 788
172 COMA 783
173 BLOOD PRESSURE DECREASED 779
174 INFLUENZA LIKE ILLNESS 769
175 HYPOGLYCAEMIA 766
176 NIGHTMARE 764
177 NECK PAIN 752
178 SPEECH DISORDER 752
179 PSYCHOTIC DISORDER 750
180 TINNITUS 749
181 GASTROINTESTINAL DISORDER 745
182 HOT FLUSH 735
183 OSTEOARTHRITIS 733
184 DYSGEUSIA 729
185 PLATELET COUNT DECREASED 727
186 PRESCRIBED OVERDOSE 721
187 HAEMATOCHEZIA 712
188 INTENTIONAL SELF-INJURY 712
189 CARDIAC FAILURE CONGESTIVE 708
190 DRUG DEPENDENCE 705
191 TYPE 2 DIABETES MELLITUS 702
192 FEELING HOT 689
193 MENTAL DISORDER 687
194 DRY SKIN 684
195 RECTAL HAEMORRHAGE 670
196 ANGER 669
197 PRODUCT QUALITY ISSUE 669
198 IMMUNODEFICIENCY 668
199 MUSCLE TWITCHING 666
200 SWELLING FACE 666
201 DYSARTHRIA 662
202 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 661
203 DELIRIUM 660
204 UNRESPONSIVE TO STIMULI 660
205 PANCREATITIS 657
206 PULMONARY OEDEMA 655
207 MULTIPLE SCLEROSIS RELAPSE 654
208 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 652
209 ADVERSE DRUG REACTION 648
210 NERVOUSNESS 641
211 MUSCULOSKELETAL PAIN 639
212 TREATMENT FAILURE 638
213 BURNING SENSATION 633
214 LEUKOPENIA 632
215 MATERNAL EXPOSURE DURING PREGNANCY 632
216 HOSPITALISATION 630
217 BLOOD CHOLESTEROL INCREASED 628
218 ILLNESS 626
219 CARDIAC DISORDER 624
220 HAEMORRHAGE 621
221 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 621
222 ABNORMAL BEHAVIOUR 620
223 EPISTAXIS 620
224 FOOD ALLERGY 618
225 BLOOD CREATININE INCREASED 608
226 TREATMENT NONCOMPLIANCE 606
227 ALANINE AMINOTRANSFERASE INCREASED 605
228 SEDATION 603
229 RHINORRHOEA 601
230 OBESITY 594
231 CROHN^S DISEASE 591
232 BURSITIS 590
233 CRYING 589
234 PRODUCTIVE COUGH 586
235 RENAL IMPAIRMENT 584
236 INJECTION SITE ERYTHEMA 582
237 PARANOIA 582
238 URINARY RETENTION 582
239 PLEURAL EFFUSION 581
240 CELLULITIS 580
241 ARRHYTHMIA 579
242 NASAL CONGESTION 577
243 RENAL FAILURE ACUTE 575
244 FLATULENCE 572
245 TEMPERATURE REGULATION DISORDER 571
246 HEART RATE DECREASED 564
247 DISEASE PROGRESSION 562
248 LOWER RESPIRATORY TRACT INFECTION 562
249 CONTRAINDICATED PRODUCT ADMINISTERED 560
250 THROMBOSIS 555
251 CARDIAC FAILURE 552
252 OEDEMA 550
253 UNEVALUABLE EVENT 549
254 SOPOR 545
255 DYSPHONIA 544
256 MENTAL STATUS CHANGES 542
257 OSTEOPOROSIS 542
258 RHABDOMYOLYSIS 542
259 DRUG TOXICITY 536
260 DYSPNOEA EXERTIONAL 532
261 CHOLELITHIASIS 527
262 ABNORMAL DREAMS 523
263 HEAD INJURY 523
264 HYPERSOMNIA 522
265 ARTHROPATHY 519
266 DEMENTIA 517
267 HERPES ZOSTER 517
268 ERECTILE DYSFUNCTION 516
269 MOOD SWINGS 516
270 TRANSIENT ISCHAEMIC ATTACK 516
271 WHITE BLOOD CELL COUNT INCREASED 506
272 AKATHISIA 505
273 ANHEDONIA 503
274 BLISTER 503
275 URINARY INCONTINENCE 503
276 DISCOMFORT 500
277 COELIAC DISEASE 499
278 POISONING 496
279 BONE PAIN 495
280 NEPHROLITHIASIS 491
281 HALLUCINATION, VISUAL 490
282 SLEEP APNOEA SYNDROME 490
283 HYPERKALAEMIA 480
284 APHASIA 478
285 HAEMATEMESIS 477
286 SWOLLEN TONGUE 476
287 MULTIPLE SCLEROSIS 475
288 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 473
289 ASPARTATE AMINOTRANSFERASE INCREASED 471
290 RESTLESS LEGS SYNDROME 467
291 CATARACT 465
292 INFLAMMATION 462
293 END STAGE RENAL DISEASE 460
294 HYPERGLYCAEMIA 458
295 PRODUCT SUBSTITUTION ISSUE 455
296 ROAD TRAFFIC ACCIDENT 455
297 RASH PRURITIC 452
298 INTERNATIONAL NORMALISED RATIO INCREASED 451
299 MOVEMENT DISORDER 451
300 BLOOD PRESSURE SYSTOLIC INCREASED 446
301 SEXUAL DYSFUNCTION 442
302 HYPOXIA 441
303 NIGHT SWEATS 441
304 CYSTITIS 440
305 DYSURIA 440
306 METABOLIC ACIDOSIS 440
307 POLLAKIURIA 440
308 RENAL INJURY 440
309 LUNG DISORDER 438
310 STOMATITIS 436
311 EYE PAIN 435
312 FREQUENT BOWEL MOVEMENTS 435
313 LIVER FUNCTION TEST ABNORMAL 434
314 FEAR 431
315 HIP FRACTURE 431
316 HEPATIC STEATOSIS 430
317 MYOCLONUS 429
318 COLITIS ULCERATIVE 428
319 MENTAL IMPAIRMENT 426
320 ORTHOSTATIC HYPOTENSION 424
321 BLOOD POTASSIUM DECREASED 423
322 LIP SWELLING 418
323 OBSESSIVE-COMPULSIVE DISORDER 417
324 PRODUCT DOSE OMISSION 416
325 POOR QUALITY SLEEP 413
326 THINKING ABNORMAL 410
327 EMOTIONAL DISORDER 409
328 ADVERSE EVENT 407
329 PNEUMONIA ASPIRATION 407
330 HYPOTHYROIDISM 403
331 HALLUCINATION, AUDITORY 402
332 BLOOD CREATINE PHOSPHOKINASE INCREASED 400
333 BLOOD PRESSURE FLUCTUATION 400
334 FEBRILE NEUTROPENIA 400
335 TORSADE DE POINTES 400
336 DRY EYE 399
337 INCREASED APPETITE 399
338 PANCYTOPENIA 398
339 MANIA 396
340 DRUG EXPOSURE DURING PREGNANCY 395
341 INTESTINAL OBSTRUCTION 395
342 MUSCLE RIGIDITY 395
343 DEVICE ISSUE 394
344 GASTRITIS 392
345 TUBULOINTERSTITIAL NEPHRITIS 392
346 SKIN EXFOLIATION 391
347 ANGIOEDEMA 388
348 INJECTION SITE BRUISING 387
349 APATHY 386
350 MELAENA 384
351 PARKINSON^S DISEASE 383
352 LYMPHADENOPATHY 376
353 MYDRIASIS 376
354 RIB FRACTURE 376
355 SINUS TACHYCARDIA 372
356 DYSSTASIA 369
357 THERAPEUTIC RESPONSE UNEXPECTED 369
358 CEREBRAL HAEMORRHAGE 368
359 MALIGNANT NEOPLASM PROGRESSION 368
360 VENTRICULAR TACHYCARDIA 368
361 MOOD ALTERED 367
362 SKIN DISCOLOURATION 367
363 IMPAIRED WORK ABILITY 364
364 CIRCULATORY COLLAPSE 362
365 THERAPY CESSATION 361
366 WRONG TECHNIQUE IN DRUG USAGE PROCESS 361
367 RED BLOOD CELL COUNT DECREASED 355
368 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 354
369 ECZEMA 353
370 DIPLOPIA 351
371 STAPHYLOCOCCAL INFECTION 350
372 ANAPHYLACTIC REACTION 348
373 DRUG EFFECT DECREASED 348
374 INTERVERTEBRAL DISC PROTRUSION 348
375 PARKINSONISM 348
376 COLITIS 345
377 PAIN IN JAW 345
378 ATRIAL SEPTAL DEFECT 343
379 VAGINAL HAEMORRHAGE 342
380 CORONARY ARTERY DISEASE 335
381 DELUSION 335
382 HAEMATOMA 335
383 HYPOPHAGIA 335
384 RETCHING 335
385 EAR INFECTION 334
386 GASTRIC DISORDER 334
387 FEELING COLD 333
388 VIRAL INFECTION 331
389 EPILEPSY 330
390 INTENTIONAL DRUG MISUSE 330
391 LOSS OF LIBIDO 330
392 EXTRAPYRAMIDAL DISORDER 329
393 JOINT STIFFNESS 329
394 ENCEPHALOPATHY 326
395 NO ADVERSE EVENT 325
396 SURGERY 325
397 THERAPEUTIC RESPONSE DECREASED 323
398 LIBIDO DECREASED 322
399 LIMB INJURY 321
400 MATERNAL DRUGS AFFECTING FOETUS 320
401 NEUTROPHIL COUNT DECREASED 320
402 INJECTION SITE PRURITUS 319
403 BODY TEMPERATURE INCREASED 317
404 INJECTION SITE SWELLING 317
405 ILL-DEFINED DISORDER 316
406 PALLOR 315
407 FOETAL DEATH 314
408 TARDIVE DYSKINESIA 314
409 DIVERTICULITIS 313
410 PSYCHOMOTOR HYPERACTIVITY 313
411 TEARFULNESS 313
412 HYPERLIPIDAEMIA 312
413 SKIN DISORDER 309
414 ACTIVITIES OF DAILY LIVING IMPAIRED 304
415 DRUG LEVEL INCREASED 304
416 ORAL PAIN 304
417 CARDIOMEGALY 303
418 INJECTION SITE REACTION 303
419 FIBROMYALGIA 301
420 THROAT IRRITATION 301
421 UNDERDOSE 301
422 BLINDNESS 300
423 BLOOD TRIGLYCERIDES INCREASED 300
424 DYSTONIA 299
425 IMPAIRED HEALING 299
426 WOUND 298
427 MULTIPLE DRUG OVERDOSE 296
428 BLOOD SODIUM DECREASED 295
429 HAEMATOCRIT DECREASED 294
430 BRUXISM 293
431 NEURALGIA 293
432 ECONOMIC PROBLEM 292
433 THERAPY INTERRUPTED 292
434 ACNE 291
435 PSORIATIC ARTHROPATHY 290
436 UPPER GASTROINTESTINAL HAEMORRHAGE 289
437 COORDINATION ABNORMAL 288
438 ANGINA PECTORIS 287
439 HAEMATURIA 287
440 LIVER DISORDER 287
441 SMALL FOR DATES BABY 287
442 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 286
443 PRESYNCOPE 286
444 C-REACTIVE PROTEIN INCREASED 285
445 LIMB DISCOMFORT 284
446 HAEMOPTYSIS 283
447 RENAL DISORDER 283
448 NEPHROGENIC ANAEMIA 282
449 DIABETES MELLITUS INADEQUATE CONTROL 281
450 FUNGAL INFECTION 281
451 INJECTION SITE HAEMORRHAGE 280
452 DISEASE RECURRENCE 278
453 EYE PRURITUS 278
454 HIATUS HERNIA 277
455 ABDOMINAL PAIN LOWER 276
456 MUSCULOSKELETAL CHEST PAIN 276
457 BLOOD GLUCOSE DECREASED 275
458 NEUROLEPTIC MALIGNANT SYNDROME 275
459 EUPHORIC MOOD 274
460 HEART RATE IRREGULAR 274
461 NEOPLASM MALIGNANT 274
462 BREAST CANCER 273
463 ABORTION SPONTANEOUS 271
464 EATING DISORDER 270
465 BLOOD ALKALINE PHOSPHATASE INCREASED 269
466 FEMUR FRACTURE 268
467 EYE SWELLING 267
468 HYPOKINESIA 267
469 MUSCLE TIGHTNESS 267
470 PULMONARY CONGESTION 266
471 MAJOR DEPRESSION 265
472 FOOT FRACTURE 264
473 RESPIRATORY DISTRESS 264
474 GALLBLADDER DISORDER 262
475 HAEMORRHOIDS 262
476 HEPATIC FAILURE 262
477 SENSORY DISTURBANCE 261
478 ABASIA 259
479 ACUTE MYOCARDIAL INFARCTION 259
480 MIDDLE INSOMNIA 259
481 EAR PAIN 258
482 HYPOACUSIS 257
483 PREGNANCY 257
484 THERAPY NON-RESPONDER 255
485 ATELECTASIS 254
486 BIPOLAR DISORDER 253
487 GAMMA-GLUTAMYLTRANSFERASE INCREASED 253
488 SKIN LESION 253
489 PHOTOSENSITIVITY REACTION 251
490 DEPRESSIVE SYMPTOM 250
491 EYE IRRITATION 249
492 HEPATITIS 249
493 RASH MACULAR 248
494 ANORGASMIA 246
495 FEELING JITTERY 245
496 PREMATURE BABY 245
497 PULMONARY HYPERTENSION 245
498 PHOTOPHOBIA 244
499 VISUAL ACUITY REDUCED 244
500 SEPTIC SHOCK 243
501 SKIN BURNING SENSATION 243
502 DEPRESSION SUICIDAL 240
503 DIABETIC KETOACIDOSIS 240
504 GASTROENTERITIS 240
505 MOUTH ULCERATION 239
506 RHINITIS 238
507 THIRST 238
508 DRUG WITHDRAWAL SYNDROME NEONATAL 237
509 GRAND MAL CONVULSION 237
510 HEMIPARESIS 237
511 RESPIRATORY DISORDER 237
512 DYSLIPIDAEMIA 236
513 TOOTH DISORDER 235
514 UPPER LIMB FRACTURE 234
515 NERVOUS SYSTEM DISORDER 233
516 ATAXIA 232
517 DEVICE MALFUNCTION 232
518 GASTRIC ULCER 232
519 ACUTE RESPIRATORY FAILURE 231
520 CLOSTRIDIUM DIFFICILE INFECTION 231
521 GAIT INABILITY 231
522 VENTRICULAR SEPTAL DEFECT 229
523 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 228
524 BONE DISORDER 226
525 CONCUSSION 226
526 FAECES DISCOLOURED 225
527 INTERSTITIAL LUNG DISEASE 225
528 RASH GENERALISED 225
529 THERAPEUTIC RESPONSE SHORTENED 225
530 SKIN ULCER 223
531 BONE DENSITY DECREASED 222
532 LYMPHOCYTE COUNT DECREASED 222
533 BRONCHIECTASIS 221
534 FOOT DEFORMITY 221
535 PANCREATITIS ACUTE 221
536 SYSTEMIC LUPUS ERYTHEMATOSUS 221
537 IMPAIRED QUALITY OF LIFE 220
538 CARDIAC MURMUR 219
539 CARPAL TUNNEL SYNDROME 219
540 DEVICE DISLOCATION 219
541 JOINT INJURY 219
542 ORAL HERPES 219
543 DRUG ADMINISTRATION ERROR 218
544 DRUG PRESCRIBING ERROR 218
545 LOCAL SWELLING 218
546 SCIATICA 218
547 HYPOMAGNESAEMIA 217
548 TOOTH FRACTURE 217
549 ALTERED STATE OF CONSCIOUSNESS 216
550 DISINHIBITION 216
551 PRURITUS GENERALISED 216
552 THROAT TIGHTNESS 216
553 THERAPEUTIC PRODUCT EFFECT DECREASED 215
554 KIDNEY INFECTION 214
555 LEUKOCYTOSIS 214
556 MUSCLE SPASTICITY 214
557 ASCITES 213
558 LABORATORY TEST ABNORMAL 213
559 RESPIRATORY DEPRESSION 212
560 ANKLE FRACTURE 211
561 COLD SWEAT 211
562 LOCALISED INFECTION 211
563 OBSTRUCTIVE AIRWAYS DISORDER 211
564 BLOOD UREA INCREASED 210
565 FEEDING DISORDER 210
566 RESPIRATORY TRACT INFECTION 210
567 SNEEZING 210
568 SUBARACHNOID HAEMORRHAGE 210
569 OSTEOPENIA 209
570 INCONTINENCE 208
571 JAUNDICE 208
572 PROCEDURAL PAIN 208
573 BLOOD BILIRUBIN INCREASED 207
574 FULL BLOOD COUNT ABNORMAL 207
575 LIVER INJURY 207
576 TOOTHACHE 207
577 BRAIN OEDEMA 206
578 EYE DISORDER 206
579 HEAD DISCOMFORT 206
580 PERSONALITY CHANGE 206
581 BRAIN INJURY 204
582 CANDIDA INFECTION 204
583 HYPOTONIA 204
584 RESPIRATORY DISORDER NEONATAL 204
585 GENERALISED TONIC-CLONIC SEIZURE 202
586 IRRITABLE BOWEL SYNDROME 202
587 ASPIRATION 201
588 PERICARDIAL EFFUSION 201
589 CEREBRAL INFARCTION 199
590 ELECTROLYTE IMBALANCE 199
591 MITRAL VALVE INCOMPETENCE 199
592 PRODUCT PRESCRIBING ERROR 199
593 PAIN OF SKIN 198
594 MICTURITION URGENCY 197
595 BLOOD POTASSIUM INCREASED 196
596 SINUS DISORDER 196
597 OSTEOMYELITIS 195
598 POST-TRAUMATIC STRESS DISORDER 195
599 INTERVERTEBRAL DISC DEGENERATION 194
600 POST PROCEDURAL COMPLICATION 194
601 PLASMA CELL MYELOMA 193
602 LACRIMATION INCREASED 192
603 PANIC REACTION 192
604 SCAR 192
605 GASTROENTERITIS VIRAL 191
606 LACERATION 191
607 PSYCHIATRIC DECOMPENSATION 191
608 BLOOD CALCIUM DECREASED 190
609 CHOKING 190
610 DIABETIC NEUROPATHY 190
611 HYPERREFLEXIA 190
612 RESPIRATORY RATE INCREASED 190
613 COAGULOPATHY 189
614 MENORRHAGIA 189
615 SPINAL OSTEOARTHRITIS 189
616 SPUTUM DISCOLOURED 189
617 DEAFNESS 188
618 SEASONAL ALLERGY 188
619 ALCOHOL POISONING 187
620 RENAL CYST 187
621 ASPHYXIA 186
622 GINGIVAL PAIN 186
623 TRANSAMINASES INCREASED 186
624 VENTRICULAR FIBRILLATION 186
625 BLOOD URINE PRESENT 185
626 BRADYPHRENIA 185
627 LUNG NEOPLASM MALIGNANT 185
628 PAROSMIA 185
629 GLOSSODYNIA 184
630 OCULAR HYPERAEMIA 184
631 SUBDURAL HAEMATOMA 184
632 DRUG EFFECT INCOMPLETE 182
633 OESOPHAGITIS 182
634 SPINAL FRACTURE 182
635 TENDERNESS 182
636 VITAMIN D DEFICIENCY 182
637 CHOLECYSTITIS CHRONIC 181
638 INJECTION SITE MASS 181
639 MULTIPLE DRUG OVERDOSE INTENTIONAL 181
640 CHROMATURIA 180
641 INITIAL INSOMNIA 178
642 SPINAL PAIN 178
643 TOOTH INFECTION 178
644 BRADYKINESIA 177
645 NEUTROPHIL COUNT INCREASED 177
646 CHOLECYSTECTOMY 176
647 FACIAL PAIN 176
648 FULL BLOOD COUNT DECREASED 176
649 HAIR COLOUR CHANGES 176
650 HAIR TEXTURE ABNORMAL 176
651 PULMONARY FIBROSIS 176
652 SHOCK 175
653 TACHYPHRENIA 175
654 ARTERIOSCLEROSIS 174
655 MYOCARDIAL ISCHAEMIA 174
656 RASH PAPULAR 174
657 STEVENS-JOHNSON SYNDROME 174
658 SUBSTANCE ABUSE 174
659 MOTOR DYSFUNCTION 173
660 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 173
661 WRIST FRACTURE 173
662 ACCIDENTAL EXPOSURE TO PRODUCT 172
663 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 172
664 CAESAREAN SECTION 172
665 PLATELET COUNT INCREASED 172
666 PSYCHOMOTOR SKILLS IMPAIRED 172
667 PULMONARY MASS 172
668 AGEUSIA 171
669 HERNIA 171
670 PRE-EXISTING CONDITION IMPROVED 171
671 LOWER LIMB FRACTURE 170
672 JOINT RANGE OF MOTION DECREASED 169
673 FRACTURE 168
674 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 168
675 HAEMORRHAGE INTRACRANIAL 167
676 SINUS CONGESTION 167
677 AFFECTIVE DISORDER 166
678 BLOOD COUNT ABNORMAL 166
679 EMPHYSEMA 166
680 OSTEONECROSIS 166
681 BLOOD PRESSURE ABNORMAL 165
682 DRUG SCREEN POSITIVE 164
683 QUALITY OF LIFE DECREASED 164
684 IRON DEFICIENCY ANAEMIA 163
685 PELVIC PAIN 163
686 ANOSMIA 162
687 BRAIN FOG 162
688 GLAUCOMA 162
689 JOINT DISLOCATION 162
690 PULSELESS ELECTRICAL ACTIVITY 162
691 SELF-INJURIOUS IDEATION 162
692 SKIN LACERATION 162
693 IMPAIRED GASTRIC EMPTYING 161
694 LACTIC ACIDOSIS 161
695 PHARYNGEAL OEDEMA 161
696 BLADDER DISORDER 160
697 BLOOD IRON DECREASED 160
698 CARDIOVASCULAR DISORDER 160
699 CHOLECYSTITIS 160
700 HYPOAESTHESIA ORAL 160
701 INTENTIONAL DOSE OMISSION 160
702 SINUS BRADYCARDIA 160
703 TENSION HEADACHE 159
704 THERAPEUTIC PRODUCT EFFECT VARIABLE 159
705 THYROID DISORDER 159
706 AFFECT LABILITY 158
707 BASAL CELL CARCINOMA 158
708 DECREASED INTEREST 158
709 FLANK PAIN 158
710 LIGAMENT SPRAIN 158
711 VENTRICULAR EXTRASYSTOLES 158
712 ABSCESS 157
713 CARDIOMYOPATHY 157
714 SOMNAMBULISM 157
715 SUSPECTED SUICIDE 157
716 ACUTE RESPIRATORY DISTRESS SYNDROME 156
717 CYANOSIS 156
718 HEPATIC CIRRHOSIS 156
719 NEONATAL RESPIRATORY DISTRESS SYNDROME 156
720 OSTEONECROSIS OF JAW 156
721 DRUG-INDUCED LIVER INJURY 155
722 PARAESTHESIA ORAL 155
723 PSYCHOLOGICAL TRAUMA 155
724 ROTATOR CUFF SYNDROME 155
725 SALIVARY HYPERSECRETION 155
726 ACCIDENTAL DEATH 154
727 ALCOHOL USE 154
728 BODY HEIGHT DECREASED 154
729 HYPERVENTILATION 154
730 INCREASED TENDENCY TO BRUISE 154
731 SMALL INTESTINAL OBSTRUCTION 154
732 ACIDOSIS 153
733 BODY TEMPERATURE DECREASED 153
734 HYPERCHOLESTEROLAEMIA 153
735 PRODUCT ADMINISTRATION ERROR 153
736 BLOOD MAGNESIUM DECREASED 152
737 DENTAL CARIES 152
738 ORAL CANDIDIASIS 152
739 PHARYNGITIS 152
740 SOCIAL AVOIDANT BEHAVIOUR 152
741 DERMATITIS ALLERGIC 150
742 KNEE ARTHROPLASTY 150
743 MUSCULOSKELETAL DISCOMFORT 150
744 GOUT 149
745 HOMICIDAL IDEATION 149
746 MULTIPLE FRACTURES 149
747 PARALYSIS 149
748 VASCULITIS 149
749 AGRANULOCYTOSIS 148
750 DERMATITIS 148
751 DIZZINESS POSTURAL 148
752 HYPOPNOEA 148
753 SUDDEN DEATH 148
754 DERMATITIS ATOPIC 146
755 PHARMACEUTICAL PRODUCT COMPLAINT 146
756 PSYCHIATRIC SYMPTOM 146
757 REBOUND ACID HYPERSECRETION 146
758 SKIN IRRITATION 146
759 GLYCOSYLATED HAEMOGLOBIN INCREASED 145
760 HYPERTONIA 145
761 MULTI-ORGAN FAILURE 145
762 PELVIC FRACTURE 145
763 ULCER 145
764 ARTERIOSCLEROSIS CORONARY ARTERY 144
765 CLOSTRIDIUM DIFFICILE COLITIS 144
766 GESTATIONAL DIABETES 143
767 NOCTURIA 143
768 PERICARDITIS 143
769 PRODUCT DOSE OMISSION IN ERROR 143
770 TOOTH ABSCESS 143
771 ANAL INCONTINENCE 142
772 DISABILITY 142
773 HYPERPARATHYROIDISM SECONDARY 142
774 LEUKAEMIA 142
775 RED BLOOD CELL SEDIMENTATION RATE INCREASED 142
776 RENAL TUBULAR NECROSIS 142
777 ALCOHOLISM 141
778 IMPAIRED DRIVING ABILITY 141
779 PNEUMONITIS 141
780 RENAL FAILURE CHRONIC 141
781 TACHYPNOEA 141
782 UROSEPSIS 141
783 HEPATOTOXICITY 140
784 MULTIPLE ORGAN DYSFUNCTION SYNDROME 140
785 SECRETION DISCHARGE 140
786 SUICIDAL BEHAVIOUR 140
787 ACCIDENT 139
788 ANOREXIA 139
789 BLOOD PRESSURE SYSTOLIC ABNORMAL 139
790 CARDIOGENIC SHOCK 139
791 DISSOCIATION 139
792 LONG QT SYNDROME 139
793 MALNUTRITION 139
794 PRESCRIBED UNDERDOSE 139
795 SPLENOMEGALY 139
796 BLOOD PRESSURE DIASTOLIC DECREASED 138
797 MUSCULOSKELETAL DISORDER 138
798 PERIPHERAL COLDNESS 138
799 RASH MACULO-PAPULAR 137
800 RESPIRATORY TRACT CONGESTION 137
801 TASTE DISORDER 137
802 ILEUS 136
803 TOOTH LOSS 136
804 DECREASED IMMUNE RESPONSIVENESS 135
805 DEVICE BREAKAGE 135
806 HALLUCINATIONS, MIXED 135
807 HYPERTHERMIA 135
808 DEVICE EXPULSION 134
809 INJECTION SITE RASH 134
810 MUCOSAL INFLAMMATION 134
811 NERVE INJURY 134
812 ATRIOVENTRICULAR BLOCK FIRST DEGREE 133
813 BACTERIAL INFECTION 133
814 ELECTROCARDIOGRAM ABNORMAL 133
815 EJECTION FRACTION DECREASED 132
816 FLUID OVERLOAD 132
817 ISCHAEMIC STROKE 132
818 LUNG INFECTION 132
819 POISONING DELIBERATE 132
820 SKIN FISSURES 132
821 FEELING DRUNK 131
822 GROIN PAIN 131
823 HYPOTHERMIA 131
824 IMPULSIVE BEHAVIOUR 131
825 NEOPLASM PROGRESSION 131
826 SLEEP TERROR 131
827 AGITATION NEONATAL 130
828 BLOOD PRESSURE DIASTOLIC ABNORMAL 130
829 CATATONIA 130
830 HYPOCALCAEMIA 130
831 MIOSIS 130
832 OVARIAN CYST 130
833 APPETITE DISORDER 129
834 BACK DISORDER 129
835 BLOOD ALBUMIN DECREASED 129
836 BLOOD TEST ABNORMAL 129
837 COMA SCALE ABNORMAL 129
838 DIVERTICULUM 129
839 HAIR DISORDER 129
840 HYPOMANIA 129
841 MENSTRUATION IRREGULAR 129
842 NEPHROPATHY 129
843 APHONIA 128
844 BEDRIDDEN 128
845 CONGENITAL ANOMALY 127
846 EXOSTOSIS 127
847 NO THERAPEUTIC RESPONSE 127
848 TENDONITIS 127
849 ABNORMAL WEIGHT GAIN 126
850 ANAPHYLACTIC SHOCK 126
851 VITAMIN D DECREASED 126
852 ECCHYMOSIS 125
853 PSYCHOMOTOR RETARDATION 125
854 CHOLESTASIS 124
855 GALACTORRHOEA 124
856 LYMPHOPENIA 124
857 CLONUS 123
858 FISTULA 123
859 LEFT VENTRICULAR HYPERTROPHY 123
860 CAROTID ARTERY OCCLUSION 122
861 CORONARY ARTERY OCCLUSION 122
862 SKIN HAEMORRHAGE 122
863 BLOOD LACTATE DEHYDROGENASE INCREASED 121
864 ERUCTATION 121
865 FACE OEDEMA 121
866 INCOHERENT 121
867 MADAROSIS 121
868 POOR VENOUS ACCESS 121
869 APNOEA 120
870 INTERVERTEBRAL DISC DISORDER 120
871 PNEUMOTHORAX 120
872 PRODUCT ADHESION ISSUE 120
873 TENSION 120
874 GLOMERULAR FILTRATION RATE DECREASED 119
875 SKIN CANCER 119
876 ABORTION INDUCED 118
877 PERITONITIS 118
878 WOUND INFECTION 118
879 CYST 117
880 GYNAECOMASTIA 117
881 MASS 117
882 PULMONARY THROMBOSIS 117
883 PURPURA 117
884 ANGIOPATHY 116
885 HUNGER 116
886 HYPERTHYROIDISM 116
887 SCHIZOPHRENIA 116
888 TRICUSPID VALVE INCOMPETENCE 116
889 BURNS SECOND DEGREE 115
890 PROTEINURIA 115
891 TEMPERATURE INTOLERANCE 115
892 MUSCLE ATROPHY 114
893 SKIN WARM 114
894 TOOTH EXTRACTION 114
895 AMENORRHOEA 113
896 DYSPHEMIA 113
897 FEELING OF BODY TEMPERATURE CHANGE 113
898 URINE OUTPUT DECREASED 113
899 ALCOHOL ABUSE 112
900 NERVE COMPRESSION 112
901 PATENT DUCTUS ARTERIOSUS 112
902 BACK INJURY 111
903 CONJUNCTIVITIS 111
904 HEPATIC ENCEPHALOPATHY 111
905 SLUGGISHNESS 111
906 CARDIOTOXICITY 110
907 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 110
908 DUODENAL ULCER 110
909 INFUSION SITE PAIN 110
910 LOOSE TOOTH 110
911 PERSONALITY DISORDER 110
912 TYPE 1 DIABETES MELLITUS 110
913 OVERWEIGHT 109
914 WEIGHT FLUCTUATION 109
915 ATRIAL TACHYCARDIA 108
916 CENTRAL NERVOUS SYSTEM LESION 108
917 PANIC DISORDER 108
918 UPPER-AIRWAY COUGH SYNDROME 108
919 BLOOD PRESSURE DIASTOLIC INCREASED 107
920 NODULE 107
921 SCRATCH 107
922 STEROID DEPENDENCE 107
923 VITREOUS FLOATERS 107
924 ANXIETY DISORDER 106
925 DECUBITUS ULCER 106
926 INCORRECT DRUG ADMINISTRATION DURATION 106
927 NYSTAGMUS 106
928 CEREBRAL ATROPHY 105
929 DEVICE RELATED INFECTION 105
930 HEPATITIS C 105
931 HIP ARTHROPLASTY 105
932 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 105
933 MUSCLE STRAIN 105
934 MYOCARDITIS 105
935 SYNOVITIS 105
936 TRISMUS 105
937 TROPONIN INCREASED 105
938 APHTHOUS ULCER 104
939 BLINDNESS UNILATERAL 104
940 BUNDLE BRANCH BLOCK LEFT 104
941 CATARRH 104
942 GASTROINTESTINAL PAIN 104
943 METASTASES TO BONE 104
944 BUNDLE BRANCH BLOCK RIGHT 103
945 DIALYSIS 103
946 FEELING OF DESPAIR 103
947 HAEMODYNAMIC INSTABILITY 103
948 SKIN INFECTION 103
949 STUPOR 103
950 DRUG USE DISORDER 102
951 EXPOSURE VIA INGESTION 102
952 FAECAL INCONTINENCE 102
953 GINGIVAL BLEEDING 102
954 PHARYNGITIS STREPTOCOCCAL 102
955 RALES 102
956 SCAB 102
957 SQUAMOUS CELL CARCINOMA 102
958 UVEITIS 102
959 FLAT AFFECT 101
960 APPLICATION SITE ERYTHEMA 100
961 LABYRINTHITIS 100
962 MALIGNANT MELANOMA 100
963 RESPIRATORY ACIDOSIS 100
964 SENSORY LOSS 100
965 STATUS EPILEPTICUS 100
966 ACUTE HEPATIC FAILURE 99
967 BLOOD GLUCOSE ABNORMAL 99
968 BRONCHOSPASM 99
969 DRY THROAT 99
970 DYSPHORIA 99
971 HOSTILITY 99
972 HYPOVOLAEMIA 99
973 METASTASES TO LIVER 99
974 PRODUCT PHYSICAL ISSUE 99
975 UTERINE LEIOMYOMA 99
976 BACTERAEMIA 98
977 EXPIRED PRODUCT ADMINISTERED 98
978 EXTRASYSTOLES 98
979 HEPATOMEGALY 98
980 INFUSION SITE ERYTHEMA 98
981 PERONEAL NERVE PALSY 98
982 SKIN PLAQUE 98
983 ALCOHOL INTERACTION 97
984 BREAST PAIN 97
985 DIARRHOEA HAEMORRHAGIC 97
986 HYSTERECTOMY 97
987 INCORRECT ROUTE OF DRUG ADMINISTRATION 97
988 INJECTION SITE WARMTH 97
989 LIVER FUNCTION TEST INCREASED 97
990 SARS-COV-2 TEST POSITIVE 97
991 DECREASED ACTIVITY 96
992 GOITRE 96
993 HAND FRACTURE 96
994 HYPERCALCAEMIA 96
995 ORAL DISCOMFORT 96
996 PRODUCT AVAILABILITY ISSUE 96
997 RENAL PAIN 96
998 URINE ABNORMALITY 96
999 ABDOMINAL TENDERNESS 95